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Radiation-Induced Neovascular Glaucoma: Dose 
and Volume Issues
Dear Editor:
I read with great interest the article by Jeon et al., titled 
‘Neovascular glaucoma following stereotactic radiosurgery 
for an optic nerve glioma: a case report’ [1]. Eight months af-
ter the patient underwent radiosurgery in the affected orbit, 
the intraglobular mass regressed to a partially residual retro-
globular nodule; however, neovascular glaucoma (NVG) de-
veloped in the same eye. The authors stated that the stereo-
tactic image-guided robotic radiosurgery using the Cyberknife 
system for the treatment of optic nerve glioma (ONG) might 
cause NVG and should be selectively utilized. Although 
there seems to be a causal relationship between radiosurgery 
and the development of NVG, some issues need to be 
clarified.
First, the authors suggested the post-radiation develop-
ment of cataract in the affected eye supports their speculation 
that radiation effects may be the most likely causative factor 
of NVG in their case. To demonstrate that a complication is 
radiation-induced, the radiation dose must be taken into 
account. The radiobiologic model of acute and late effects on 
normal human organs according to the radiation dose and 
volume has been well established through in vivo and in vitro 
studies, and it is true that radiotherapy can affect the retina, 
lens, conjunctiva, lacriminal apparatus, optic nerve, and 
eyelids. However, retinitis and optic neuropathy are found to 
occur following only high doses of radiation greater than 50 
to 65 Gy, whereas cataracts are reported to develop following 
small radiation doses as low as 10 to 18 Gy, due to the differ-
ences in the sensitivities of the normal organs [2]. In the pres-
ent case, the total irradiated dose of 16 Gy in four fractions 
was sufficiently high to cause lens opacity but was too low to 
have any effects on the retina or the optic nerve (16 Gy of 
four fractions equals 25 Gy with 2 Gy per fraction according 
to the biologically effective dose calculation, α/β=3). In the 
uveal melanoma cases, which the authors referred to as 
“NVG after stereotactic radiosurgery for intraocular tumors,” 
the target dose for the tumor apex was set at greater than 100 
Gy. Moreover, plaque brachytherapy was used in those mela-
noma cases, instead of stereotactic radiosurgery [3].
Second, the volume irradiated is also an important factor in 
the development of NVG. Recently, Hirasawa et al. [4] found 
radiation damage to the anterior segment of the eye and the 
optic disk to be a risk factor for NVG based on a dose–vol-
ume histogram analysis. In their study, both the dose to the 
anterior segment of the eye and the optic disc and the volume 
irradiated with greater than 50 Gy were statistically sig-
nificant factors contributing to the development of NVG. 
Current advances in planning techniques for stereotactic ra-
diosurgery aimed to minimize the dose to the anterior seg-
ment and the disc can reduce the risk of this complication. 
One of these new instruments, the CyberKnife robotic radio-
surgery system (Accuray, Sunnyvale, CA, USA), used in this 
case, enables delivery of high radiation doses to the target 
with a much steeper dose gradient outside the tumor volume 
compared with those of other treatment systems that have 
been reported to produce NVG [5]. Using the Cyberknife 
system, far less than 50% of the total dose generally affects 
the anterior segment of the eye. Dose and volume issues need 
to be carefully considered when determining the cause- 
and-effect relationships between radiation therapy and its as-
sociated complications.
Ah Ram Chang
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We hypothesized that the target tissue is an important issue 
in this case. Kline et al. [1] included patients with pituitary 
lesion, and the radiation effect focused on the pituitary gland 
would be attenuated in ocular tissue. The radiation plan for 
melanoma would be localized to the specific retinal lesion 
[2,3] and would have an effect on the adjacent vitreous and 
optic disc. Radiation to the entire intraconal optic nerve and 
optic nerve head will show distinct responses because they 
contain the central retinal artery and veins. If the central reti-
nal artery and veins are damaged, whether by the destroyed 
adjacent tissue or from the radiation itself, the ocular blood 
flow will be severely disturbed, and various cytokine levels, 
such as vascular endothelial growth factor, will be elevated, 
a condition which is known to cause neovascular glaucoma 
(NVG) [4,5]. In this case, NVG developed after low-dose ra-
diation to the optic nerve, and we believe that this illustrates 
the need for careful planning of radiation therapy on the op-
tic nerve.
Sohee Jeon, Chan-Kee Park
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